Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under PACIFIC BIOSCIENCES OF CALIFORNIA, INC. in our court records and SEC 8-K records (as of 2026-10-18).
- Layoffs: 1 exit or restructuring plan reported on Form 8-K, Item 2.05 (latest filed 2026-08-05, about 40 jobs).
- Leadership changes: the latest reported is Christopher M. Smith, Director (Form 8-K filed 2026-07-09). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Ark Investment Management LLC (filed 2026-08-14).
Who is behind it
Pacific Biosciences of California, Inc.: incorporated in Delaware; business address in Menlo Park, California; industry Laboratory Analytical Instruments (Schedule 13G/A, 2026-08-14).
Officers and directors, each with the role and the filing that names them:
- David Botstein: Director (Form D, 2023-10-19)
- William W. Ericson: Director (Form D, 2023-10-19)
- Christian O. Henry: Executive Officer, Director (Form D, 2023-10-19)
- Randall S. Livingston: Director (Form D, 2023-10-19)
- David Meline: Director (Form D, 2023-10-19)
- John F. Milligan: Director (Form D, 2023-10-19)
- Marshall Mohr: Director (Form D, 2023-10-19)
- Kathy Ordonez: Director (Form D, 2023-10-19)
- Lucy A. Shapiro: Director (Form D, 2023-10-19)
- Hannah A. Valentine: Executive Officer (Form D, 2023-10-19)
- Susan Kim: Executive Officer (Form D, 2023-10-19)
- Mark Van Oene: Executive Officer (Form D, 2023-10-19)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-08-14 | Ark Investment Management LLC | 9.59% |
| Schedule 13G/A, 2026-03-27 | The Vanguard Group | 0% |
| Schedule 13G/A, 2026-02-03 | Ark Investment Management LLC | 12.34% |
| Schedule 13G/A, 2025-11-14 | Gregory Boyd Penner | 2.8% |
| Schedule 13G/A, 2025-11-04 | Ark Investment Management LLC | 10.3% |
| Schedule 13G/A, 2025-08-13 | Gregory Boyd Penner | 6.8% |
| Schedule 13G/A, 2025-07-24 | Edmond De Rothschild Asset Management (France) | 4.5% |
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-07-09 | Christopher M. Smith | Director | departed |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2023-10-19 | $84.76M | $84.76M |
| Form D, 2023-08-17 | $85M | $85M |
Acquisitions reported on Form 8-K, Item 2.01: completed an acquisition (2026-02-02).
Red flags found
1 exit or restructuring plan on Form 8-K (latest Form 8-K, 2026-08-05).
Related pages
LayoffsLeadership changes5%+ holders
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
Permanent URL:
https://mentionfox.com/who-owns/pacific-biosciences-of-californiaLast updated 2026-10-18
Primary record: Schedule 13G/A, 2026-08-14 · Form D, 2023-10-19 · Form 8-K, 2026-07-09 · Form D, 2023-08-17
Who owns Pacific Biosciences of California, Inc.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/pacific-biosciences-of-california